Carbylan Therapeutics Inc. (CBYL) 7.02 $CBYL
InsiderInsights.com Daily Round Up 4/14/15: BH, NXRT, AGCO, COSI
InsiderInsights - at Seeking Alpha - Wed Apr 15, 8:55AM CDT
CLMS: 12.47 (+0.01), HII: 139.76 (+0.55), KODK: 20.06 (-0.46), AGCO: 48.16 (-0.16), BALT: 1.61 (+0.08), SAM: 261.44 (-2.60), NXRT: 13.95 (+0.01), ABDC: 13.70 (-0.19), TIF: 85.10 (+0.95), CBYL: 7.02 (-0.38), MFRM: 63.45 (-0.24), BH: 396.99 (-5.47), MENT: 24.80 (+0.47), COSI: 2.66 (+0.06), LGF: 31.24 (+0.10), VRNT: 64.23 (-0.21), KTEC: 13.00 (+0.13), ALCO: 48.09 (-1.52)
Carbylan Therapeutics, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
GlobeNewswire - Tue Apr 14, 3:30PM CDT
Carbylan Therapeutics, Inc. (Nasdaq:CBYL) (the "Company"
today announced the closing of its initial public offering of 14,950,000 shares of its common stock at an initial public offering price of $5.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 1,950,000 additional shares of common stock. All of the shares of common stock were offered by the Company. The Company estimates net proceeds from the offering to be approximately $66.1 million, after deducting underwriting discounts and commissions and estimated offering expenses.
CBYL: 7.02 (-0.38)
U.S. IPO Weekly Recap: 2 US IPOs Feature First Chinese Tech Offering Of 2015
Renaissance Capital IPO Research - at Seeking Alpha - Sat Apr 11, 3:48AM CDT
Just two small and delayed IPOs - a Chinese e-commerce company and a biotech - raised $105 million this week as management typically avoids investor roadshows before Easter. The real action in the IPO market came from names like Party City (Pending:...
WOWO: 8.41 (-0.88), VIRT: 21.81 (-0.54), ADRO: 38.17 (-0.50), PRTY: 20.65 (-0.22), VRAY: (), ETSY: 25.12 (-0.63), CBYL: 7.02 (-0.38)
Seeking Alpha's Biotech Weekly: A Biogen Deep Dive, Eisai's Arena Shuffle, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Apr 10, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
BIIB: 423.57 (+1.46), SPHS: 0.82 (+0.01), ADMS: 17.62 (-0.21), TKMR: 18.38 (-0.14), CBYL: 7.02 (-0.38), HPTX: 45.96 (-0.18), QURE: 26.15 (-1.44), SHPG: 253.58 (+3.70), SRPT: 13.52 (+0.04), HZNP: 30.96 (+0.10), GALE: 1.39 (unch), JUNO: 55.72 (-0.68), ABBV: 64.52 (+0.91), CBMG: 32.14 (+2.21), ARNA: 4.47 (+0.01), EXEL: 3.12 (+0.05), ADXS: 22.18 (+0.10), PTLA: 38.48 (-0.47), BMY: 66.60 (-0.21), OCUL: 25.90 (-0.05), NVO: 56.37 (-0.17), DVA: 83.22 (+0.10), HALO: 16.03 (+0.15), GILD: 104.18 (-1.02), MRK: 57.69 (+0.03), AZN: 73.35 (+0.65), ALXN: 188.19 (+1.41), NVS: 103.45 (-0.62)
Carbylan Therapeutics Continues The Trend Of Unexciting Biopharma IPOs
APBK Capital - at Seeking Alpha - Thu Apr 09, 2:13PM CDT
CBYL: 7.02 (-0.38)
Carbylan Therapeutics, Inc. Announces Pricing of Initial Public Offering
GlobeNewswire - Wed Apr 08, 5:42PM CDT
Carbylan Therapeutics, Inc. (the "Company" today announced the pricing of its initial public offering of 13,000,000 shares of its common stock at a price to the public of $5.00 per share. The shares will be listed on the NASDAQ Global Market and will trade under the ticker symbol "CBYL" beginning on April 9, 2015. The Company is offering all 13,000,000 shares of common stock. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 1,950,000 shares of common stock.
CBYL: 7.02 (-0.38)
U.S. IPO Weekly Recap: Big Data Produces Small Returns In A Selective IPO Market
Renaissance Capital IPO Research - Seeking Alpha - Sat Feb 14, 11:07PM CST
Five companies had below-average returns and brought the number of 2015 IPOs up to 22, a 39% decline from this time last year... • 5 of 12 IPOs got done ; 2nd week in a row where less than half of possible deals priced •Even as the IPO...
IDGX: (), AGMX: (), SLWD: (), ITEK: 4.80 (-0.02), REDX: (), AVNU: 11.75 (unch), INOV: 25.83 (+0.17), CBYL: 7.02 (-0.38), NVTA: 12.76 (-1.12), AJX: 14.36 (-0.02), BLPH: 9.98 (-0.08)
Anika Therapeutics files Cingal regulatory apps in U.S. and Europe
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 2:42PM CST
MNK: 122.95 (-2.22), FLXN: 18.77 (-0.78), XENE: 14.25 (-0.66), HZNP: 30.96 (+0.10), AMPE: 2.89 (+0.20), CBYL: 7.02 (-0.38), ANIK: 38.68 (+0.05)
Week Ahead: 12 IPOs Feature Healthcare, Holdovers And A $500 Million Health Tech IPO
Renaissance Capital IPO Research - Seeking Alpha - Mon Feb 09, 9:36AM CST
Twelve deals are on the calendar to raise $1.2 billion, which would make it the year's biggest week for IPOs by proceeds and count. However, those numbers could fall decline if the week ahead is similar to last week, which saw seven of eight...
IDGX: (), AGMX: (), SLWD: (), CHEK: 4.40 (-0.17), ITEK: 4.80 (-0.02), REDX: (), AVNU: 11.75 (unch), INOV: 25.83 (+0.17), CBYL: 7.02 (-0.38), NVTA: 12.76 (-1.12), BLPH: 9.98 (-0.08)
IPO Preview: Carbylan Therapeutics
IPOdesktop - Seeking Alpha - Fri Feb 06, 8:57AM CST
Based in Palo Alto, CA, Carbylan Therapeutics (NASDAQ: CBYL ) scheduled a $75 million IPO on Nasdaq with a market capitalization of $198 million at a price range midpoint of $13 for Wednesday, Feb. 4, 2015. The full IPO calendar is available at ...
CBYL: 7.02 (-0.38)
IPO Market Set For Another Surge In The Healthcare Sector
Renaissance Capital IPO Research - at Seeking Alpha - Mon Feb 02, 6:15PM CST
Ten IPOs are on the IPO calendar to raise $1.4 billion, led by an $800 million offering of natural gas pipelines. The MLP is joined by a government-focused REIT as the two dividend-producing IPOs seek to price late in the week. The remaining eight...
AVGR: 11.66 (+0.23), IDGX: (), SLWD: (), ITEK: 4.80 (-0.02), REDX: (), INOV: 25.83 (+0.17), PUMP: (), CBYL: 7.02 (-0.38), NVET: 8.61 (-0.27), AAAP: ()
Flexion patient dosing underway in lead product study
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 3:27PM CST
MNK: 122.95 (-2.22), FLXN: 18.77 (-0.78), XENE: 14.25 (-0.66), HZNP: 30.96 (+0.10), AMPE: 2.89 (+0.20), CBYL: 7.02 (-0.38), ANIK: 38.68 (+0.05)
Carbylan Therapeutics on deck for IPO
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 12:13PM CST
MNK: 122.95 (-2.22), FLXN: 18.77 (-0.78), XENE: 14.25 (-0.66), HZNP: 30.96 (+0.10), AMPE: 2.89 (+0.20), ANIK: 38.68 (+0.05), CBYL: 7.02 (-0.38)
InsiderInsights.com Daily Round Up 4/14/15: BH, NXRT, AGCO, COSI
InsiderInsights - at Seeking Alpha - Wed Apr 15, 8:55AM CDT
CLMS: 12.47 (+0.01), HII: 139.76 (+0.55), KODK: 20.06 (-0.46), AGCO: 48.16 (-0.16), BALT: 1.61 (+0.08), SAM: 261.44 (-2.60), NXRT: 13.95 (+0.01), ABDC: 13.70 (-0.19), TIF: 85.10 (+0.95), CBYL: 7.02 (-0.38), MFRM: 63.45 (-0.24), BH: 396.99 (-5.47), MENT: 24.80 (+0.47), COSI: 2.66 (+0.06), LGF: 31.24 (+0.10), VRNT: 64.23 (-0.21), KTEC: 13.00 (+0.13), ALCO: 48.09 (-1.52)
Carbylan Therapeutics, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
GlobeNewswire - Tue Apr 14, 3:30PM CDT
Carbylan Therapeutics, Inc. (Nasdaq:CBYL) (the "Company"
today announced the closing of its initial public offering of 14,950,000 shares of its common stock at an initial public offering price of $5.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 1,950,000 additional shares of common stock. All of the shares of common stock were offered by the Company. The Company estimates net proceeds from the offering to be approximately $66.1 million, after deducting underwriting discounts and commissions and estimated offering expenses. CBYL: 7.02 (-0.38)
U.S. IPO Weekly Recap: 2 US IPOs Feature First Chinese Tech Offering Of 2015
Renaissance Capital IPO Research - at Seeking Alpha - Sat Apr 11, 3:48AM CDT
Just two small and delayed IPOs - a Chinese e-commerce company and a biotech - raised $105 million this week as management typically avoids investor roadshows before Easter. The real action in the IPO market came from names like Party City (Pending:...
WOWO: 8.41 (-0.88), VIRT: 21.81 (-0.54), ADRO: 38.17 (-0.50), PRTY: 20.65 (-0.22), VRAY: (), ETSY: 25.12 (-0.63), CBYL: 7.02 (-0.38)
Seeking Alpha's Biotech Weekly: A Biogen Deep Dive, Eisai's Arena Shuffle, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Apr 10, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
BIIB: 423.57 (+1.46), SPHS: 0.82 (+0.01), ADMS: 17.62 (-0.21), TKMR: 18.38 (-0.14), CBYL: 7.02 (-0.38), HPTX: 45.96 (-0.18), QURE: 26.15 (-1.44), SHPG: 253.58 (+3.70), SRPT: 13.52 (+0.04), HZNP: 30.96 (+0.10), GALE: 1.39 (unch), JUNO: 55.72 (-0.68), ABBV: 64.52 (+0.91), CBMG: 32.14 (+2.21), ARNA: 4.47 (+0.01), EXEL: 3.12 (+0.05), ADXS: 22.18 (+0.10), PTLA: 38.48 (-0.47), BMY: 66.60 (-0.21), OCUL: 25.90 (-0.05), NVO: 56.37 (-0.17), DVA: 83.22 (+0.10), HALO: 16.03 (+0.15), GILD: 104.18 (-1.02), MRK: 57.69 (+0.03), AZN: 73.35 (+0.65), ALXN: 188.19 (+1.41), NVS: 103.45 (-0.62)
Carbylan Therapeutics Continues The Trend Of Unexciting Biopharma IPOs
APBK Capital - at Seeking Alpha - Thu Apr 09, 2:13PM CDT
CBYL: 7.02 (-0.38)
Carbylan Therapeutics, Inc. Announces Pricing of Initial Public Offering
GlobeNewswire - Wed Apr 08, 5:42PM CDT
Carbylan Therapeutics, Inc. (the "Company"
today announced the pricing of its initial public offering of 13,000,000 shares of its common stock at a price to the public of $5.00 per share. The shares will be listed on the NASDAQ Global Market and will trade under the ticker symbol "CBYL" beginning on April 9, 2015. The Company is offering all 13,000,000 shares of common stock. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 1,950,000 shares of common stock. CBYL: 7.02 (-0.38)
U.S. IPO Weekly Recap: Big Data Produces Small Returns In A Selective IPO Market
Renaissance Capital IPO Research - Seeking Alpha - Sat Feb 14, 11:07PM CST
Five companies had below-average returns and brought the number of 2015 IPOs up to 22, a 39% decline from this time last year... • 5 of 12 IPOs got done ; 2nd week in a row where less than half of possible deals priced •Even as the IPO...
IDGX: (), AGMX: (), SLWD: (), ITEK: 4.80 (-0.02), REDX: (), AVNU: 11.75 (unch), INOV: 25.83 (+0.17), CBYL: 7.02 (-0.38), NVTA: 12.76 (-1.12), AJX: 14.36 (-0.02), BLPH: 9.98 (-0.08)
Anika Therapeutics files Cingal regulatory apps in U.S. and Europe
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 2:42PM CST
MNK: 122.95 (-2.22), FLXN: 18.77 (-0.78), XENE: 14.25 (-0.66), HZNP: 30.96 (+0.10), AMPE: 2.89 (+0.20), CBYL: 7.02 (-0.38), ANIK: 38.68 (+0.05)
Week Ahead: 12 IPOs Feature Healthcare, Holdovers And A $500 Million Health Tech IPO
Renaissance Capital IPO Research - Seeking Alpha - Mon Feb 09, 9:36AM CST
Twelve deals are on the calendar to raise $1.2 billion, which would make it the year's biggest week for IPOs by proceeds and count. However, those numbers could fall decline if the week ahead is similar to last week, which saw seven of eight...
IDGX: (), AGMX: (), SLWD: (), CHEK: 4.40 (-0.17), ITEK: 4.80 (-0.02), REDX: (), AVNU: 11.75 (unch), INOV: 25.83 (+0.17), CBYL: 7.02 (-0.38), NVTA: 12.76 (-1.12), BLPH: 9.98 (-0.08)
IPO Preview: Carbylan Therapeutics
IPOdesktop - Seeking Alpha - Fri Feb 06, 8:57AM CST
Based in Palo Alto, CA, Carbylan Therapeutics (NASDAQ: CBYL ) scheduled a $75 million IPO on Nasdaq with a market capitalization of $198 million at a price range midpoint of $13 for Wednesday, Feb. 4, 2015. The full IPO calendar is available at ...
CBYL: 7.02 (-0.38)
IPO Market Set For Another Surge In The Healthcare Sector
Renaissance Capital IPO Research - at Seeking Alpha - Mon Feb 02, 6:15PM CST
Ten IPOs are on the IPO calendar to raise $1.4 billion, led by an $800 million offering of natural gas pipelines. The MLP is joined by a government-focused REIT as the two dividend-producing IPOs seek to price late in the week. The remaining eight...
AVGR: 11.66 (+0.23), IDGX: (), SLWD: (), ITEK: 4.80 (-0.02), REDX: (), INOV: 25.83 (+0.17), PUMP: (), CBYL: 7.02 (-0.38), NVET: 8.61 (-0.27), AAAP: ()
Flexion patient dosing underway in lead product study
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 3:27PM CST
MNK: 122.95 (-2.22), FLXN: 18.77 (-0.78), XENE: 14.25 (-0.66), HZNP: 30.96 (+0.10), AMPE: 2.89 (+0.20), CBYL: 7.02 (-0.38), ANIK: 38.68 (+0.05)
Carbylan Therapeutics on deck for IPO
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 12:13PM CST
MNK: 122.95 (-2.22), FLXN: 18.77 (-0.78), XENE: 14.25 (-0.66), HZNP: 30.96 (+0.10), AMPE: 2.89 (+0.20), ANIK: 38.68 (+0.05), CBYL: 7.02 (-0.38)
